Literature DB >> 33454821

Bowel function recovery after laparoscopic transverse colectomy within an ERAS program: a comparison to right and left colectomy.

Raffaello Roesel1, Francesco Mongelli2, Costanza Ajani2, Fabiano Iaquinandi2, Diana Celio2, Dimitri Christoforidis2,3.   

Abstract

BACKGROUND: It is known that functional recovery of the bowel is slower after right colectomy (RC) compared to left colectomy (LC), but very little has been reported on transverse colectomy (TC).
OBJECTIVES: The aim of this study was to compare the clinical and early functional outcomes of TC, a more infrequent operation, to RC, and LC for colorectal cancer.
METHODS: Between December 2011 and December 2017, all patients undergoing elective colon resection in our institution were treated according to a standardized ERAS protocol and entered in a prospective database. We included in the study patients undergoing laparoscopic TC, RC, or LC for cancer with curative intent. The primary endpoint was prolonged postoperative ileus (PPOI), defined as need to insert a nasogastric tube, or refractory nausea VAS > 4 on or after the third postoperative day. Secondary endpoints were postoperative morbidity and length of hospital stay (LoS).
RESULTS: Out of 286 patients, 126 met the inclusion criteria: 20 underwent TC, 65 RC, and 41 LC. Patients in LC group were younger than in TC and RC groups; other baseline demographics were similar. PPOI was observed in 5 (25%), 26 (40%), and 10 (24%) patients in TC, RC, and LC groups, respectively (p = 0.417). In single group comparisons, the incidence of PPOI in the TC group was significantly lower in comparison to the RC group (OR for RC: 4.255, 95% CI 1.092-16.667, p = 0.037) and similar to the LC group. No significant differences in terms of postoperative complications or LoS stay were observed.
CONCLUSION: The incidence of PPOI after segmental laparoscopic colectomy for cancer within an ERAS program appears as infrequent in TC as in LC and lower than after RC. It may be reasonable to consider a slower oral intake after RC, as it represents an independent predictor of PPOI.

Entities:  

Keywords:  Colon cancer; Colorectal surgery; ERAS; Enhanced recovery; Laparoscopy; Transverse

Year:  2021        PMID: 33454821     DOI: 10.1007/s00423-021-02082-3

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  15 in total

1.  Operative Method for Transverse Colon Carcinoma: Transverse Colectomy Versus Extended Colectomy.

Authors:  Choon Seng Chong; Jung Wook Huh; Bo Young Oh; Yoon Ah Park; Yong Beom Cho; Seong Hyeon Yun; Hee Cheol Kim; Woo Yong Lee
Journal:  Dis Colon Rectum       Date:  2016-07       Impact factor: 4.585

2.  Clinicopathologic characteristics, surgical treatment and outcomes for splenic flexure colon cancer.

Authors:  Chan Wook Kim; Ui Sup Shin; Chang Sik Yu; Jin Cheon Kim
Journal:  Cancer Res Treat       Date:  2010-06-30       Impact factor: 4.679

3.  Guidelines for perioperative care in elective colonic surgery: Enhanced Recovery After Surgery (ERAS(®)) Society recommendations.

Authors:  U O Gustafsson; M J Scott; W Schwenk; N Demartines; D Roulin; N Francis; C E McNaught; J Macfie; A S Liberman; M Soop; A Hill; R H Kennedy; D N Lobo; K Fearon; O Ljungqvist
Journal:  World J Surg       Date:  2013-02       Impact factor: 3.352

Review 4.  Defining postoperative ileus: results of a systematic review and global survey.

Authors:  Ryash Vather; Sid Trivedi; Ian Bissett
Journal:  J Gastrointest Surg       Date:  2013-02-02       Impact factor: 3.452

5.  Enhanced Recovery Pathway for Right and Left Colectomy: Comparison of Functional Recovery.

Authors:  Anne Kummer; Juliette Slieker; Fabian Grass; Dieter Hahnloser; Nicolas Demartines; Martin Hübner
Journal:  World J Surg       Date:  2016-10       Impact factor: 3.352

6.  A characterization of factors determining postoperative ileus after laparoscopic colectomy enables the generation of a novel predictive score.

Authors:  Udo Kronberg; Ravi P Kiran; Mohamed S M Soliman; Jeff P Hammel; Ursula Galway; John Calvin Coffey; Victor W Fazio
Journal:  Ann Surg       Date:  2011-01       Impact factor: 12.969

7.  Comparison of extended hemicolectomy versus transverse colectomy in patients with cancer of the transverse colon.

Authors:  I van Rongen; R A M Damhuis; J A B van der Hoeven; P W Plaisier
Journal:  Acta Chir Belg       Date:  2013 Mar-Apr       Impact factor: 1.090

8.  Tumor subsite location within the colon is prognostic for survival after colon cancer diagnosis.

Authors:  Charlie M Wray; Argyrios Ziogas; Marcelo W Hinojosa; Hoa Le; Michael J Stamos; Jason A Zell
Journal:  Dis Colon Rectum       Date:  2009-08       Impact factor: 4.585

9.  Short- and long-term outcomes for patients with splenic flexure tumours treated by left versus extended right colectomy are comparable: a retrospective analysis.

Authors:  Manfred Odermatt; Najaf Siddiqi; Rose Johns; Danilo Miskovic; Omar Khan; Jim Khan; Amjad Parvaiz
Journal:  Surg Today       Date:  2013-12-04       Impact factor: 2.549

10.  Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.

Authors:  Daniel Dindo; Nicolas Demartines; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

View more
  2 in total

1.  Bowel recovery after intra- vs extra-corporeal anastomosis for oncologic laparoscopic right hemicolectomy within an ERAS protocol: a retrospective study.

Authors:  S G Popeskou; Zs Horvath; F Mongelli; R Roesel; A Cristaudi; F Garofalo; D Christoforidis
Journal:  Langenbecks Arch Surg       Date:  2022-06-21       Impact factor: 2.895

2.  Enhanced Recovery after Surgery (ERAS) Protocol Is a Safe and Effective Approach in Patients with Gastrointestinal Fistulas Undergoing Reconstruction: Results from a Prospective Study.

Authors:  Stanislaw Klek; Jerzy Salowka; Ryszard Choruz; Tomasz Cegielny; Joanna Welanyk; Mariusz Wilczek; Kinga Szczepanek; Magdalena Pisarska-Adamczyk; Michal Pedziwiatr
Journal:  Nutrients       Date:  2021-06-07       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.